Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
CellPly
Bologna, Italy
B
11-50 Employees
2013
Key takeaway
Cellply is focused on developing analytical tools that enhance the efficiency of cancer cell therapy development, which directly relates to cell line development. Their expertise in various technologies, including AI and biology, supports their mission to advance therapeutic innovations.
Reference
Core business
Cellply
Adaltis
Montecelio, Italy
B
251-500 Employees
1987
Key takeaway
Adaltis specializes in the development and production of in-vitro diagnostic systems, including a strong focus on hybridomas and monoclonal antibody production. Their expertise in customized services and a wide range of assays positions them as a key player in the field of molecular diagnostics.
Reference
Service
Adaltis S.r.l. - Hybridomas (Cell Lines) & Monoclonal Antibody Production
Explora Biotech
Rome, Italy
B
11-50 Employees
2006
Key takeaway
Explora Bioscience Srl is a Contract Research Organisation that specializes in the development and preclinical validation of advanced-therapy medicinal products (ATMPs), including cell-based therapies. Their integrated services support the entire process, making them a valuable partner for companies focused on innovative treatments like gene therapy and regenerative medicine.
Reference
Service
CUSTOM SERVICES - Explora Biotech
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
InnovaVector
Pozzuoli, Italy
B
11-50 Employees
2019
Key takeaway
InnovaVector is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Adeno-Associated Viral (AAV) vectors for both non-clinical and clinical applications. With over twenty years of expertise in AAV production and characterization, the company is well-equipped to support the development of gene therapies through its innovative solutions and commitment to high-quality GMP AAV batches.
Reference
Product
Process and Analytical development - Innovavector
Rigenerand Srl
Medolla, Italy
B
11-50 Employees
2009
Key takeaway
Rigenerand specializes in developing and producing cGMP products for cell and gene therapy, with a focus on advanced therapeutic medicinal products (ATMP). The company also creates innovative 3D culture biomedical devices that enhance diagnostic and therapeutic applications.
Reference
Product
Mihara K, Imai C, Coustan-Smith E, Dome JS, Dominici M, Vanin E, Campana D. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol. 2003 Mar;120:846-9. - Rigenerand
Cellex
Rome, Italy
B
1-10 Employees
1995
Key takeaway
Cellex specializes in the development of advanced bioreactors for cell culture and tissue engineering, with a particular focus on their innovative SUSPENCE® bioreactor that enhances cell growth by keeping them in suspension. This expertise in bioreactor technology directly supports their work in cell line development.
Reference
Core business
Cell expansion devices - cellex
CLONIT SRL
Milan, Italy
B
11-50 Employees
1987
Key takeaway
Clonit has a strong focus on developing innovative molecular diagnostic equipment and reagents, which may relate to their expertise in analytical methods that could be applicable in cell line development. Their commitment to high standards and quality assurance suggests a reliable partnership for laboratories engaged in advanced biotechnological research.
Reference
Product
Clonit Products
Reithera Srl
Rome, Italy
B
101-250 Employees
2005
Key takeaway
ReiThera specializes in the development and production of genetic vaccines using innovative technologies, including their expertise in viral cell culture and GMP manufacturing. With a focus on advanced therapies, they offer comprehensive support for translational research and clinical trials.
Reference
Core business
An ideal partner for your translational research • Reithera
We develop and produce biopharmaceutical products for advanced therapies, in order to treat several serious or life-threatening diseases.
MyWay Genetics
Stradella, Italy
B
1-10 Employees
2016
Key takeaway
The company is an Italian Innovative Start-up that emphasizes personalized medicine through a unique model that incorporates multidisciplinary skills and constant research. Their focus on optimizing sample preparation processes and developing tailored data pipelines suggests a commitment to advanced methodologies that could be relevant to cell line development.
Reference
Service
Personal laboratory | MyWay Genetics
We support you in engineering your personal laboratory, comprising optimization of sample preparation processes, developing ad hoc pipelines for data
IGA Technology Services
Udine, Italy
B
11-50 Employees
2008
Key takeaway
The company, IGATech, utilizes advanced sequencing technologies and innovative strategies to enhance plant and animal breeding efficiency, which is relevant to cell line development. Their expertise in molecular biology and bioinformatics supports sustainable development goals through research and services that explore genome structure and functionality.
Reference
Product
Technologies / Illumina Certified Service Provider | IGATech
Technologies which have been searched by others and may be interesting for you:
When exploring the Cell Line Development industry in Italy, several key considerations emerge. Italy hosts a robust biotechnology sector, with numerous companies specializing in cell line development for research and therapeutic applications. Understanding regulatory frameworks is crucial, as compliance with EU regulations and specific Italian guidelines can significantly impact project timelines and costs. The industry faces challenges such as high competition and the need for continuous innovation to meet market demands. Opportunities exist in collaborations with academic institutions and participation in EU-funded research programs, which can enhance research capabilities and funding prospects. Additionally, the global market relevance of Italian cell line developers is growing, driven by increasing demand for biopharmaceuticals and personalized medicine. Environmental concerns are also critical, particularly regarding the sustainability of bioprocessing practices. Companies are increasingly focusing on eco-friendly methods and reducing their carbon footprint. The competitive landscape includes both established firms and startups, creating a dynamic environment for investment and growth. Overall, thorough research into these factors can aid in identifying potential partners or investment opportunities in Italy's cell line development sector.
Some interesting numbers and facts about your company results for Cell Line Development
| Country with most fitting companies | Italy |
| Amount of fitting manufacturers | 172 |
| Amount of suitable service providers | 131 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1987 |
| Youngest suiting company | 2019 |
Some interesting questions that has been asked about the results you have just received for Cell Line Development
What are related technologies to Cell Line Development?
Based on our calculations related technologies to Cell Line Development are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Cell Line Development?
The most represented industries which are working in Cell Line Development are Biotechnology, Other, Pharmaceuticals, Medical, IT, Software and Services
How does ensun find these Cell Line Development Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.